P2.03-035 Osimertinib in Relapsed EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases: Results from the TREM-Study

Autor: Eide, I.J., Helland, Å., Borrisova, S., Ekman, S., Cicenas, S., Koivunen, J., Grønberg, B.H., Brustugun, O.T.
Zdroj: In Journal of Thoracic Oncology November 2017 12(11) Supplement 2:S2140-S2141
Databáze: ScienceDirect